5 ms·
Nasal version of the Oxford/AstraZeneca Covid vaccine fails in U.K. trial
- Markoff 4y ago>The nasal version of the Oxford/AstraZeneca COVID vaccine failed to elicit an antibody response in an early trial, and the company is shelving its development.